Literature DB >> 25231558

Safflower yellow inhibits angiotensin II-induced adventitial fibroblast proliferation and migration.

Yueqiang Liu1, Xuefeng Tian, Mingzhu Cui, Suzhen Zhao.   

Abstract

Safflower yellow (SY) has been widely used in Chinese medicine for the treatment of ischemic cardiocerebrovascular disease. Recent studies have indicated that SY has a reverse effect on vascular remodeling (VR). However, its detailed mechanisms require further study to provide more scientific evidence for the clinical treatment of VR. This study aims to investigate the effects of SY on angiotensin II (Ang II)-induced cell proliferation, migration, apoptosis, and extracellular matrix in rat aortic adventitial fibroblasts (AFs). The proliferation and migration rates of AFs treated with Ang II for 24 h were higher than those of untreated AFs; and increases in the expression of p-ERK1/2, AP-1, collagen I, and collagen III were observed. Treatment with SY significantly downregulated cell proliferation, migration, and the expression of p-ERK1/2, AP-1, collagen I, and collagen III. We also found that the cell percentage of apoptosis of AFs treated with Ang II for 24 h was lower than those of untreated AFs. After treatment with SY, the percentage of apoptosis was increased. SY exhibits anti-proliferative, anti-migratory, and pro-apoptotic activities in rat aortic AFs, perhaps through the Ang II/ERK/AP-1 signaling pathway. The present findings may provide new clues regarding the potential function of SY to treat or prevent VR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25231558     DOI: 10.1254/jphs.14055fp

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  6 in total

1.  Examining the effector mechanisms of Xuebijing injection on COVID-19 based on network pharmacology.

Authors:  Wen-Jiang Zheng; Qian Yan; Yong-Shi Ni; Shao-Feng Zhan; Liu-Liu Yang; Hong-Fa Zhuang; Xiao-Hong Liu; Yong Jiang
Journal:  BioData Min       Date:  2020-10-16       Impact factor: 2.522

2.  Effects of Safflower Yellow on the Treatment of Severe Sepsis and Septic Shock: A Randomized Controlled Clinical Trial.

Authors:  Xiao-Jin Li; Ru-Rong Wang; Yan Kang; Jin Liu; Yun-Xia Zuo; Xue-Feng Zeng; Gong Cheng
Journal:  Evid Based Complement Alternat Med       Date:  2016-02-18       Impact factor: 2.629

3.  XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial.

Authors:  Yuanlin Song; Chen Yao; Yongming Yao; Hui Han; Xiaodong Zhao; Kaijiang Yu; Luyi Liu; Ying Xu; Zhongmin Liu; Qingshan Zhou; Ying Wang; Zhuang Ma; Youguang Zheng; Dawei Wu; Zhongzhi Tang; Minzhou Zhang; Shuming Pan; Yanfen Chai; Yan Song; Jian Zhang; Lei Pan; Yi Liu; He Yu; Xuezhong Yu; Hong Zhang; Xiaoge Wang; Zhaohui Du; Xianyao Wan; Yijun Tang; Yingping Tian; Yimin Zhu; Hongliang Wang; Xiaoyan Yan; Zhi Liu; Boli Zhang; Nanshan Zhong; Hongcai Shang; Chunxue Bai
Journal:  Crit Care Med       Date:  2019-09       Impact factor: 7.598

4.  The efficacy and safety of Xuebijing injection in the treatment of radiation pneumonitis: A protocol for systematic review and meta-analysis.

Authors:  Zheng Li; Dandan Wang; Ying Zhang; Shuo Wang; Xueqian Wang; Yuxiao Li; Yuerong Gui; Jun Dong; Wei Hou
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

Review 5.  The Repression of the HMGB1-TLR4-NF-κB Signaling Pathway by Safflower Yellow May Improve Spinal Cord Injury.

Authors:  Lu Wang; Benson O A Botchway; Xuehong Liu
Journal:  Front Neurosci       Date:  2021-12-24       Impact factor: 4.677

6.  Marked Reduction in 28-day Mortality Among Elderly Patients with Severe Community-acquired Pneumonia: Post Hoc Analysis of a Large Randomized Controlled Trial.

Authors:  Yan Liu; Chi Zhang; Chengyu Li; Chunxue Bai; Hongcai Shang
Journal:  Clin Interv Aging       Date:  2020-11-09       Impact factor: 4.458

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.